Septin Mutations in Human Cancers.

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Septins are GTP-binding proteins evolutionarily linked to RAS oncogenes.
• Altered septin expression is implicated in cancer progression, but septin mutations in human cancers are poorly understood.
• This review focuses on missense septin mutations within the Catalog of Somatic Mutations in Cancer (COSMIC) database.

Approach:

• Systematic review of missense septin mutations from the COSMIC database.
• Analysis of mutation distribution across different septin genes and tumor types.
• Identification of recurring mutations in conserved amino acid residues and functional domains.

Key Points:

• The majority of septin mutations are observed in large intestine, skin, endometrium, and stomach tumors.
• SEPT9 and SEPT14 show the highest mutation frequencies in skin, stomach, and large intestine cancers.
• Recurring mutations target conserved amino acids within GTP-binding pockets and dimerization interfaces.

Conclusions:

• Septin mutations, while occurring at low frequencies (<3%), are recurrent and found in critical functional regions.
• Further research is needed to elucidate the functional impact of these somatic mutations on cancer progression.
• Septin mutations may hold potential as tumor-specific biomarkers.